Jeremy M Levin
CIK 1256153 · View on SEC EDGAR ↗
First SEC filing: May 4, 2017 · Latest: May 4, 2017
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 11, 2025 | OVID | P | 71 | — | — | 71 Direct | — | Acquired | (price as of 2026-08-21) |
| Dec. 11, 2025 | OVID | P | 47,333 | — | — | 47,333 Direct | — | Acquired | (price as of 2026-08-21) |
| Dec. 11, 2025 | OVID | P | 35,500 | — | — | 35,500 Direct | — | Acquired | (price as of 2026-08-21) |
| March 18, 2024 | OVID | P | 18,248 | $2.76 | $50,364 | 3,616,715 Direct | +0.51% | Acquired | 1.4% (price as of 2026-08-21) |
| Aug. 28, 2020 | OVID | P | 8,488 | $5.84 | $49,570 | 5,792,530 Direct | +0.15% | Acquired | -52.1% (price as of 2026-08-21) |
| Oct. 8, 2019 | OVID | P | 60,000 | $2.50 | $150,000 | 4,736,529 Direct | +1.28% | Acquired | 12.0% (price as of 2026-08-21) |
| Feb. 22, 2019 | OVID | P | 75,000 | $2.00 | $150,000 | 4,676,529 Direct | +1.63% | Acquired | 40.0% (price as of 2026-08-21) |
| Aug. 25, 2017 | OVID | P | 15,334 | $7.15 | $109,638 | 4,601,529 Direct | +0.33% | Acquired | -60.8% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| March 23, 2026 | OVID | Series A Warrant (right to buy) | Common Stock (47,333) | $1.40 | April 17, 2026 | 47,333 | Disposed |
| Feb. 26, 2026 | OVID | Employee Stock Option (Right to Buy) | Common Stock (957,000) | $1.65 | Feb. 25, 2036 | 957,000 | Acquired |
| Dec. 15, 2025 | OVID | Series B Convertible Preferred Stock | Common Stock (71,000) | — | — | 71 | Disposed |
| Dec. 11, 2025 | OVID | Series B Convertible Preferred Stock | Common Stock (71,000) | — | — | 71 | Acquired |
| Dec. 11, 2025 | OVID | Series A Warrant (right to buy) | Common Stock (47,333) | $1.40 | — | 47,333 | Acquired |
| Dec. 11, 2025 | OVID | Series B Warrant (right to buy) | Common Stock (35,500) | $1.40 | Oct. 6, 2030 | 35,500 | Acquired |
| Feb. 20, 2025 | OVID | Employee Stock Option (Right to Buy) | Common Stock (1,650,000) | $0.57 | Feb. 19, 2035 | 1,650,000 | Acquired |
| Feb. 22, 2024 | OVID | Stock Option (Right to Buy) | Common Stock (700,000) | $3.68 | Feb. 21, 2034 | 700,000 | Acquired |
| Feb. 23, 2023 | OVID | Stock Option (Right to Buy) | Common Stock (600,000) | $2.50 | Feb. 22, 2033 | 600,000 | Acquired |
| April 8, 2022 | OVID | Stock Option (Right to Buy) | Common Stock (423,244) | $3.22 | April 7, 2032 | 423,244 | Acquired |
| Feb. 3, 2022 | OVID | Stock Option (Right to Buy) | Common Stock (600,000) | $2.72 | Feb. 2, 2032 | 600,000 | Acquired |
| Dec. 17, 2020 | OVID | Stock Option (Right to Buy) | Common Stock (650,000) | $2.82 | Dec. 16, 2030 | 650,000 | Acquired |
| Dec. 18, 2019 | OVID | Stock Option (Right to Buy) | Common Stock (600,000) | $4.42 | Dec. 17, 2029 | 600,000 | Acquired |
| Feb. 24, 2019 | OVID | Employee Stock Option (Right to Buy) | Common Stock (250,000) | $1.89 | Feb. 23, 2029 | 250,000 | Acquired |
| Jan. 19, 2018 | OVID | Employee Stock Option (Right to Buy) | Common Stock (290,000) | $9.18 | Jan. 18, 2028 | 290,000 | Acquired |
| May 10, 2017 | OVID | Series B Preferred Stock | Common Stock (35,461) | — | — | 35,461 | Disposed |
| May 10, 2017 | OVID | Series A Preferred Stock | Common Stock (400,150) | — | — | 400,150 | Disposed |
| Oct. 1, 2011 | BMY | Restricted Stock Units | Common Stock, $0.10 par value (10,000) | — | Oct. 1, 2011 | 10,000 | Disposed |
| March 4, 2011 | BMY | Restricted Stock Units | Common Stock, $0.10 par value (1,397) | — | March 4, 2012 | 1,397 | Disposed |
| March 3, 2011 | BMY | Restricted Stock Units | Common Stock, $0.10 par value (2,019) | — | March 3, 2013 | 2,019 | Disposed |
| March 2, 2011 | BMY | Market Share Units | Common Stock, $0.10 par value (2,307) | — | — | 2,307 | Disposed |
| March 1, 2011 | BMY | Performance Shares | Common Stock, $0.10 par value (9,046) | — | March 31, 2011 | 9,046 | Disposed |
| March 1, 2011 | BMY | Performance Shares | Common Stock, $0.10 par value (3,898) | — | — | 3,898 | Disposed |
| March 1, 2011 | BMY | Performance Shares | Common Stock, $0.10 par value (282) | — | — | 282 | Acquired |
| March 1, 2011 | BMY | Performance Shares | Common Stock, $0.10 par value (2,682) | — | — | 2,682 | Acquired |
| March 1, 2011 | BMY | Performance Shares | Common Stock, $0.10 par value (3,898) | — | — | 3,898 | Acquired |
| March 1, 2011 | BMY | Performance Shares | Common Stock, $0.10 par value (5,516) | — | — | 5,516 | Acquired |
| March 1, 2011 | BMY | Market Share Units | Common Stock, $0.10 par value (11,312) | — | — | 11,312 | Acquired |
| Oct. 1, 2010 | BMY | Restricted Stock Units | Common Stock, $0.10 par value (10,000) | — | Oct. 1, 2011 | 10,000 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 18 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 4, 2017 | OVID | Common Stock | 4,186,045 | Direct |
| May 4, 2017 | OVID | Common Stock | 465,116 | Indirect |
| May 4, 2017 | OVID | Series A Preferred Stock→ Common Stock (400,150) | 400,150 | Direct |
| May 4, 2017 | OVID | Series B Preferred Stock→ Common Stock (35,461) | 35,461 | Indirect |
| May 4, 2017 | OVID | Employee Stock Option (Right to Buy)→ Common Stock (372,093) | 372,093 | Direct |
| May 4, 2017 | OVID | Employee Stock Option (Right to Buy)→ Common Stock (186,046) | 186,046 | Direct |
| May 4, 2017 | OVID | Employee Stock Option (Right to Buy)→ Common Stock (232,558) | 232,558 | Direct |
| May 14, 2010 | BMY | Common Stock, $0.10 par value | 20,505 | Direct |
| May 14, 2010 | BMY | Market Share Units→ Common Stock, $0.10 par value (9,228) | 9,228 | Direct |
| May 14, 2010 | BMY | Option (right to buy)→ Common Stock, $0.10 par value (42,941) | 42,941 | Direct |
| May 14, 2010 | BMY | Option (right to buy)→ Common Stock, $0.10 par value (25,000) | 25,000 | Direct |
| May 14, 2010 | BMY | Option (right to buy)→ Common Stock, $0.10 par value (25,509) | 25,509 | Direct |
| May 14, 2010 | BMY | Option (right to buy)→ Common Stock, $0.10 par value (80,000) | 80,000 | Direct |
| May 14, 2010 | BMY | Performance Shares→ Common Stock, $0.10 par value (9,046) | 9,046 | Direct |
| May 14, 2010 | BMY | Performance Shares→ Common Stock, $0.10 par value (2,987) | 2,987 | Direct |
| May 14, 2010 | BMY | Restricted Stock Units→ Common Stock, $0.10 par value (20,000) | 20,000 | Direct |
| May 14, 2010 | BMY | Restricted Stock Units→ Common Stock, $0.10 par value (2,794) | 2,794 | Direct |
| May 14, 2010 | BMY | Restricted Stock Units→ Common Stock, $0.10 par value (6,058) | 6,058 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $644,054 | — | — | — | $532,000 | — | $14,000 | $1,934,699 |
| 2024 | $625,296 | — | — | — | $292,326 | — | $13,800 | $2,774,102 |
| 2023 | $625,296 | — | — | — | $390,810 | — | $13,920 | $2,136,546 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.